Dermatology Treatment Devices is Expected to Dominate the Asia-Pacific Dermatology Devices Market in 2016” – A New Report by Data Bridge Market Research

Asia-Pacific Dermatology Devices Market, By Product Type (Dermatology Treatment Devices and Dermatology Diagnostic Devices), By End-User (Hospitals and Clinics) By Country (Japan, China, India, Australia, South Korea, Others) – Trends and Forecast to 2022

The rising incidence of skin disorders such as melanoma and non-melanoma skin cancer, vascular and pigmented lesions, varicose veins, psoriasis, and acne, coupled with an increasing awareness amongst the patients have triggered the market for both diagnostic and treatment devices in the field of dermatology. In comparison with the U.S., a low incidence rate of melanoma (≤1/100 000) was reported in the East Asian countries that include Taiwan, China, Japan, Korea, Hong Kong, and Singapore. The most common subtype in these countries covers acral lentiginous melanoma, which includes approximately 50% to 58% of cutaneous melanoma. The number of skin cancer cases in Singapore has been increasing. There were 2,819 cases of skin cancer in Singapore between 2008 and 2012, among which 83.0% were Chinese, according to the National Skin Centre, followed by the people from Malaysia recording 4.5% of the cases.

An in-depth profiling of the key players have been conducted, along with the recording of the recent developments (including new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by the companies to sustain and strengthen their positions in the APAC dermatology devices market. The major companies operating in the APAC market are Heine Optotechnik, Optomed Oy, FotoFinder Systems, Michelson Diagnostics, Genesis Biosystems, Ellipse A/S , Alma Lasers, Palomar Technologies, GE Healthcare, and Philips Healthcare, 3Gen LLC, Welch Allyn, Carl Zeiss Meditec, Inc., Hitachi, Leica Microsystems, Olympus, Toshiba Medical Systems, and Siemens Medical Systems.


Or visit